134 related articles for article (PubMed ID: 11684932)
1. Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil.
de Pinho AM; Santoro-Lopes G; Harrison LH; Schechter M
AIDS; 2001 Nov; 15(16):2129-35. PubMed ID: 11684932
[TBL] [Abstract][Full Text] [Related]
2. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
[TBL] [Abstract][Full Text] [Related]
3. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
[TBL] [Abstract][Full Text] [Related]
4. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
[TBL] [Abstract][Full Text] [Related]
7. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
[TBL] [Abstract][Full Text] [Related]
8. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
[TBL] [Abstract][Full Text] [Related]
9. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
Gray DM; Zar H; Cotton M
Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
[TBL] [Abstract][Full Text] [Related]
10. [Tuberculin test, antitubercular chemoprophylaxis and incidence of tuberculosis in a Swiss HIV cohort study].
Sudre P; Rieder H; Bassetti S; Hirschel B; Ledergerber B; Malvy D
Rev Epidemiol Sante Publique; 1997 Apr; 45(2):171-3. PubMed ID: 9221445
[No Abstract] [Full Text] [Related]
11. Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.
Gourevitch MN; Hartel D; Selwyn PA; Schoenbaum EE; Klein RS
AIDS; 1999 Oct; 13(15):2069-74. PubMed ID: 10546859
[TBL] [Abstract][Full Text] [Related]
12. Treatment of latent tuberculosis infection in HIV infected persons.
Woldehanna S; Volmink J
Cochrane Database Syst Rev; 2004; (1):CD000171. PubMed ID: 14973947
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro.
Souza CT; Hökerberg YH; Pacheco SJ; Rolla VC; Passos SR
Mem Inst Oswaldo Cruz; 2009 May; 104(3):462-7. PubMed ID: 19547873
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
[TBL] [Abstract][Full Text] [Related]
15. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.
da Silva Escada RO; Velasque L; Ribeiro SR; Cardoso SW; Marins LMS; Grinsztejn E; da Silva Lourenço MC; Grinsztejn B; Veloso VG
BMC Infect Dis; 2017 May; 17(1):373. PubMed ID: 28558689
[TBL] [Abstract][Full Text] [Related]
16. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil.
Golub JE; Durovni B; King BS; Cavalacante SC; Pacheco AG; Moulton LH; Moore RD; Chaisson RE; Saraceni V
AIDS; 2008 Nov; 22(18):2527-33. PubMed ID: 19005276
[TBL] [Abstract][Full Text] [Related]
17. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
Alaei K; Alaei A; Mansouri D
East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
[TBL] [Abstract][Full Text] [Related]
18. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
Saraceni V; Durovni B; Cavalcante SC; Cohn S; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
Braz J Infect Dis; 2014; 18(5):491-5. PubMed ID: 24780362
[TBL] [Abstract][Full Text] [Related]
19. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P
Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316
[TBL] [Abstract][Full Text] [Related]
20. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration.
Whalen C; Okwera A; Johnson J; Vjecha M; Hom D; Wallis R; Huebner R; Mugerwa R; Ellner J
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1977-81. PubMed ID: 8665064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
